H.R. 6130, the ASAP Act, advanced out of committee on September 16, 2026.
H.R. 6130 — ASAP Act
What it does
This bill amends Medicare law to cover blood-based screening tests for early-stage Alzheimer's disease and related dementias, effective January 1, 2028. The tests must be FDA-cleared, classified, or approved, and include blood tests, genomic sequencing, protein analysis, and related biomarker tests. Medicare will pay for these screenings as a covered benefit.
Quorum's transparency scan gave ASAP Act a moderate transparency flag.
What happens next
H.R. 6130 advanced out of committee. Next stop: a floor vote.
Who is behind it
Filed by Vern Buchanan. Cosponsored by Aaron Bean, Abraham Hamadeh, Adam Gray and Addison McDowell.
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.